Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

A review of safety, quality management, and practice guidelines for high-dose-rate brachytherapy: executive summary. Pract Radiat Oncol 2014 Mar-Apr;4(2):65-70 PMID: 24890345

Pubmed ID

24890345

DOI

10.1016/j.prro.2013.12.005

Abstract

This white paper was commissioned by the American Society for Radiation Oncology (ASTRO) Board of Directors to evaluate the status of safety and practice guidance for high-dose-rate (HDR) brachytherapy. Given the maturity of HDR brachytherapy technology, this white paper considers, from a safety point of view, the adequacy of general physics and quality assurance guidance, as well as clinical guidance documents available for the most common treatment sites. The rate of medical events in HDR brachytherapy procedures in the United States in 2009 and 2010 was 0.02%, corresponding to 5-sigma performance. The events were not due to lack of guidance documents but failures to follow those recommendations or human failures in the performance of tasks. The white paper summarized by this Executive Summary reviews current guidance documents and offers recommendations regarding their application to delivery of HDR brachytherapy. It also suggests topics where additional research and guidance is needed.

Author List

Thomadsen BR, Erickson BA, Eifel PJ, Hsu IC, Patel RR, Petereit DG, Fraass BA, Rivard MJ

Author

Beth A. Erickson MD Professor in the Radiation Oncology department at Medical College of Wisconsin




Scopus

2-s2.0-84896731204   22 Citations

MESH terms used to index this publication - Major topics in bold

Brachytherapy
Humans
Patient Safety
Practice Guidelines as Topic
Quality of Health Care
Radiation Oncology
United States
jenkins-FCD Prod-353 9ccd8489072cb19f5b9f808bb23ed672c582f41e